From: Extracellular vesicles: a rising star for therapeutics and drug delivery
Surface modification | Strategy | EVs source | Functions | Refs. |
---|---|---|---|---|
Genetic engineering | Infection with PGMLV-PA6 virus expressing both the CXCR4 protein and GFP | MSCs | Allowed more MSC-derived exosomes to nest around the target region | [139] |
 | Transfection via the pCDH-GFP vector | HuCMSCs | Decreased ATP concentration; increased adenosine levels; and reduced spinal cord inflammation | [140] |
 | Transfection via the recombinant adenoviral vector GFP-CTF1 encoding CTF1 | BMSCs | Increased proangiogenic activity and the rates of successful pregnancy outcomes | [141] |
 | Transfection via a pCDNA-MEG3 vector | OS cells | Inhibition of osteosarcoma growth | [143] |
 | Introduction of pcDNA3.1(-)-RGD-Lamp2b into cells by electroporation | HEK293T | Enhanced tumor site targeting | [145] |
 | Transfection via a miR-31-5p lentiviral vector | HEK293 | Promoted the healing of diabetic wounds | [144] |
 | Co-transfection of a reporter plasmid and miR-181b mimics using Lipofectamine | Human umbilical cord mesenchymal stem cells (HuCMSCs) | Enhanced M2 polarization; inhibited inflammation; and promoted osseointegration | [244] |
 | Transfection via an XStamp-PDGFA lentiviral vector | Neural stem cells (NSCs) | Improved potential for CNS injury targeting | [245] |
 | Transfection via an LV-iRGD-Lamp2b lentiviral vector | Human cord blood MSCs (cbMSCs) | Enhanced targeting to tumor sites | [246] |
 | Transfection via a Lenti-XStamp-PDGFA lentiviral vector | Neural stem cells (NSCs) | Enhanced targeting efficiency for central nervous system lesions | [247] |
 | Transfection via the pRBP-Lamp2b-HA-hygro vector using Lipofectamine 2000 | HEK293 cells | Anti-inflammatory effects | [248] |
 | Transfection via the iRGDC1-EGFP-Lamp2b virus | HEK293T | Enhanced tumor targeting | [249] |
Bioorthogonal chemistry | The azide groups were bioorthogonally labeled with DBCO-Cy5 via bioorthogonal click chemistry | A549 | Exosome tracking and imaging | [148] |
 | DBCO reacted with azide or azide-containing methionine analogs via bioorthogonal click chemistry | B16F10 | Regulation of exosome composition and binding of exosomes for intracellular delivery | [147] |
 | DBCO-Exo was linked to a c(RDGyK) peptide with an azide moiety via copper-free click chemistry | MSCs | Improved targeting of lesion sites | [149] |
 | Copper-free click chemistry was used with AlexaFlour®488 (AF488)-azide | PANC-1 B16F10 HEK293 | Achieved quantification of intracellular tracking and intracellular uptake | [150] |
Physical modification | Membrane extrusion method | HCC | Enhanced targeting ability and improved siRNA transfection efficiency | [153] |
 | Lipid membrane fusion | Sf9 insect cells | Enhanced targeting capabilities | [154] |
 | Membrane extrusion method | SKOV3-CDDP | Enhanced targeting capabilities | [155] |
 | Membrane extrusion method | L-929 | Depleted cells and homing effects | [156] |
 | Membrane fusion technology using the freeze–thaw method | CT26 | Allowed immune evasion, enhanced targeting ability, and acted as a drug carrier | [157] |
 | PEG-mediated membrane fusion | HUVECs | Widely used in studies on the mechanism of membrane fusion | [158] |
 | Membrane extrusion method | J774A.1 | Enhanced targeting ability and acted as a drug carrier | [159] |
 | Incubation-mediated membrane fusion | HEK293FT | Enabled efficient wrapping of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) in exosomes | [250] |
 | Incubation | HEK293T | Improved targeting capabilities | [251] |
 | Electrostatic interaction | MSCs | Targeted hepatocyte asialoglycoprotein receptors | [160] |
 | Extrusion method | Bone marrow MSCs | Improved targeting ability and promoted angiogenesis | [161] |
Chemical modification | Bioconjugate chemistry | Human leukemia monocytic cell line (THP-1) | Promoted blood–brain barrier penetration and improved targeting | [164] |
 | Copper-free click chemistry | M2-BV2 | Provided rapid and effective recruitment and differentiation transformation of neural stem cells | [165] |
 | Cycloaddition reaction of sulfonyl azide | U-87 MG | Improved targeting | [166] |
 | Hydrophobic insertion method | ADMSCs | Improved targeting | [167] |
 | Lipid insertion method | BMSCs | Improved targeting | [168] |
 | PDA self-polymerization and thiol-Michael addition reactions | L929 | Facilitated fluorescent labeling | [169] |
 | Hydrophobic interaction (lipid insertion method) | MSCs derived from human induced pluripotent stem cells (iPSCs) | Improved targeting | [170] |
 | Thiol-maleimide click reaction | Milk | Facilitated fluorescent labeling and improved targeting | [171] |
 | Phospholipid insertion method | Primary human adipose-derived stem cells | Improved targeting | [252] |
 | Phospholipid insertion method | Milk | Improved targeting | [253] |
 | Phospholipid insertion method | HepG2 | Photothermal effects and improved targeting | [254] |
 | EDC/NHS chemistry | MSCs | Improved targeting | [255] |
 | Membrane anchoring | B16F10 | Improved targeting and imaging capabilities | [256] |
 | Lipid-anchoring method | BMDCs | Improved specificity for T cells | [257] |